首页 › 癌症（所有类型） › 得克萨斯州 › Irving
Irving TX 癌症（所有类型）临床试验
14项针对 癌症（所有类型）的研究正在 Irving及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
招募中1/2 期
- NEXT Oncology ( Site 1012), Irving
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
招募中1 期
- NEXT Dallas, Irving
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Dallas, Irving
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
招募中1 期
- NEXT Oncology ( Site 0051), Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
招募中1 期
- NEXT Oncology Dallas, Irving
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- NEXT Oncology Dallas, Irving
REC-7735 in Participants With Solid Tumors
招募中1/2 期
- NEXT Oncology - Dallas, Irving
Registry Study for Radiation Therapy Outcomes
招募中观察性研究
- Texas Center for Proton Therapy, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Dallas, Irving
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Dallas, Irving
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
招募中1/2 期
- NEXT Oncology, Irving
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
招募中1 期
- NEXT Oncology, Irving
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
招募中1/2 期
- NEXT Dallas, Irving
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
招募中观察性研究
- Texas Center for Proton Therapy, Irving
其他城市的 癌症（所有类型）试验
- Houston, TX124 项研究
- New York City, NY105 项研究
- Boston, MA90 项研究
- Los Angeles, CA73 项研究
- Nashville, TN65 项研究
- Durham, NC61 项研究
- Washington, DC60 项研究
- Philadelphia, PA57 项研究
- Arlington, VA52 项研究
- Chicago, IL51 项研究
- St. Louis, MO51 项研究
- Atlanta, GA49 项研究
Irving的其他研究
- 非小细胞肺癌23 项研究
- 结直肠癌15 项研究
- 转移性癌症10 项研究
- 胃癌9 项研究
- 头颈鳞状细胞癌8 项研究
- 乳腺癌8 项研究
- 胰腺癌7 项研究
- 卵巢癌7 项研究
- 小细胞肺癌6 项研究
- 子宫内膜癌6 项研究
- 食管癌5 项研究
- 肺癌5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。